Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Radionuclide Imaging × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1

Conditions

Interventions

Blood Specimen Collection 16 Cyclophosphamide 10 Photochemotherapy 9 Standard of Care 8 Educational Status 8 fludarabine phosphate 7 Radiotherapy 7 Radiosurgery 7 Peripheral Blood Stem Cell Transplantation 7 Cyclosporine 7 Biopsy 7 Tomography, Optical Coherence 6 Surveys and Questionnaires 6 Practice Guidelines as Topic 6 Methods 6 Filgrastim 6 Early Intervention, Educational 6 Whole-Body Irradiation 5 Surgical Procedures, Operative 5 Psychiatric Rehabilitation 5 Mycophenolic Acid 5 Melphalan 5 Aminolevulinic Acid 5 Therapeutics 4 Magnetic Resonance Spectroscopy 4 Dermoscopy 4 Curettage 4 Antilymphocyte Serum 4 pembrolizumab 3 methyl 5-aminolevulinate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06666790 2024-10-31

DermaSensor Postmarket Surveillance Study

DermaSensor, Inc.

Phase NA Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡